Ezihlanganisiweyo i-linoleic acids (CLA) 95% (121250-47-3)

Februwari 27, 2020

IConjugated Linoleic Acid, okanye i-CLA, ligama elisetyenziselwa ukubhekisa kumxube weeasidi ezinamanqwanqwa jikelele ………

 


Isimo: KwiMveliso yoLuntu
I-Synthesized and Customized Available
Amandla: 1277kg / inyanga

 

Ividiyo ye-linoleic acid (i-CLA) ye-95% (121250-47-3) edibeneyo

I-linoleic acid edityanisiweyo (i-CLA) Suqobo

Igama lemveliso Ukudibanisa i-linoleic acid (CLA) 95%
Igama leKhemikhali 9,11-Linoleic acid; 9,11-Octadecadienoic acid; I-Linolenic Acid edibeneyo, i-CLA; i-CIS-10, i-CIS-12-OCTADECADIENOICACID; I-CIS-10-CIS-12-CONJUGATEDLINOLEICACID; IITRANS-10, IITRANS-12-OCTADECADIENOICIC Ukudibanisa i-linoleic acid - i-Microencapsulated solid; I-Octadecadienoic Acid (Conjugic Acidd, cis-9, Trtans-11) (C18: 2)
uhlobo Numama N / A
Iqela leziyobisi N / A
Inani leCAS 121250-47-3
InChIKey I-OYHQOLUKZRVURQ-HZJYTTRNSA-N
I molecular Fi-ormula C18H32O2
I molecular WSibhozo 280.44
IMasaisotopic Mass 280.24023 g / mol
Indawo yokubilisa  I-444 ukuya kwi-446 ° F kwi-16 mm Hg (NTP, 1992)
Fukuhlaziywa kwakhona Point N / A
I-Biological Half-Life Amandla oxutywe ngokulula nomoya.
umbala Olwelo
Sukufaneleka  Iinyibilika ngokukhululekileyo kwi-ether; inyibilikise butywala ngokupheleleyo; I-1 mL inyibilikisa i-10 mL ye-petroleum ether; ukungahambi kakuhle nge-dimethylformamide, izinyibilikisi ezinamafutha, ioyile
Sisibetho Tukushisa  Gcina kwi -20 ° C
Aukuguquka Intsapho ye-8 yejometri isomers ze-linoleic acid

 

Yintoni i-Conjugated linoleic acid (CLA)?

I-Linoleic Acid edibeneyo, okanye i-CLA, ligama elisetyenziselwa ukubhekisa kumxube wamanqatha ane-asidi enesakhiwo esipheleleyo se-linoleic acid (ii-carbons ezili-18 ubude, ii-2 bond ezimbini) apho izibophelelo ezibini zikho iikhabhathi ezimbini ukusuka kwenye; Zonke zinamanqatha e-polyunsaturated acid, kwaye ezinye zinokuba ziintsholongwane ezinamafutha.

I-Cinoledic Linoleic Acid (CLA) yethu iveliswa yitekhnoloji yokutsalwa kolwelo oluphezulu. I-CLA ithengiswa njengesongezelelo sokutya ngokwesiseko sezibonelelo zempilo. Esi sisongezo esidumileyo sokutya esithengiswayo kunye namabango okunceda abantu ukuba balahle amanqatha, bagcine ubunzima bokunciphisa umzimba, bagcine ubunzima bemisipha, kunye nolawulo lwe-2 yeswekile- uhlobo lwesifo seswekile esihlala sinxulunyaniswa nokutyeba kakhulu. I-CLA ibonakalisiwe ukuba ibonelela ngezibonelelo ezininzi zempilo ngokubhekisele kwisifo sentliziyo, umhlaza, ukutyeba kakhulu, i-osteoporosis kunye ne-immune system.

Abanye bakholelwa ukuba i-CLA inokukhulisa ukusebenza komzimba ngelixa iphucula i-cholesterol ephezulu kunye namanqanaba oxinzelelo lwegazi. Ngaphandle kokuthandwa kwayo phakathi kwezinye iimbaleki, ubungqina buhlala buqhekeziwe malunga nokuba i-CLA inako na ukwenza ezi zithembiso.

Ukudityaniswa kwezibonelelo ze-linoleic acid (CLA)

I-CLA yinto yemvelo enamafutha acid afumaneka kwizilwanyana ezithile nakwiimveliso zokutya zezilwanyana, njengenkomo yomhlaba kunye nokunye ukutya, itshizi kunye nobisi-iintlobo zokutya ezihlala zingafakwanga kwizicwangciso zokutya. Kuba umzimba womntu awunakuvelisa i-CLA, singayifumana ngokutya okanye izongezo zethu ukuze sivune izibonelelo.

I-CLA inokunciphisa i-lipids yegazi, ithambise imithambo yegazi, uxinzelelo lwegazi olusezantsi, kwaye ikhuthaze ukubonwa kwezinto ezincinci, inokuthintela okanye inciphise isifo sesifo sentliziyo, ngakumbi uxinzelelo lwegazi oluphezulu, i-cholesterol ephezulu, i-angina, isifo sentliziyo, i-atherosclerosis, kunye ne-senile obesity Ukulawulwa kokuqina okunamandla kakhulu, kunokuthintela i-serum cholesterol yomntu kwindawo ekugcinwa kuyo iindonga zegazi, abe negama elithi "vascular scavenger", ukuthintela nokunyanga isifo se-atherosclerosis kunye nesifo sentliziyo esinemiphumela yempilo.

Izinzuzo zezeMpilo

  1. Inceda ngokunciphisa umzimba kunye nokutsha ngamanqatha
  2. Ukulawula iswekile yegazi kunye nokuNceda ukuphucula ukuSebenza kwe-insulin
  3. Ukuphucula ukuSebenza ngokuSebenza kunye nokuNceda ukuCeba uMhlaza
  4. Ukucutha i-Allergies kunye neempawu ze-Asthma
  5. Ukuphuculwa kweempawu zesifo samathambo
  6. Amandla okuphucula amandla emisipha
  7. Ukutshintsha i-atherosulinosis (ukuqina kwemithambo)
  8. Ukuphucula ukugaya ukutya kunye nezinto ezivalelayo
  9. ukunceda ukuguqula amanqanaba eswekile yegazi

I-linoleic acid edityanisiweyo (i-CLA) umyinge

I-FDA ivumela i-CLA ukuba yongezwe kukutya kwaye iyinike i-GRAS (ngokubanzi ithathwa njengekhuselekile) imeko.

Uninzi lwezifundo kwi-CLA zisebenzise iidosi ezi-3-6 zegram ngosuku. Iidosi ezinkulu kune-6 zegrem zinonyusa umngcipheko weziphumo ebezingalindelekanga.

 

I-linoleic acid edityanisiweyo (i-CLA) Iziphumo ezinokubakho.

I-linoleic acid (i-CLA) edityanisiweyo iye yanikwa indawo ethi "Ngokubanzi ihlonitshwe njengeKhuselekileyo" e-US ukuba isetyenziswe njengesongezelelo sokutya. Ithathwa njengekhuselekileyo ukusebenzisa i-CLA ukuba ithathwe njengoko kumiselwe, abanye abantu banokufumana iziphumo ebezingalindelekanga, zihlala zilulamile, kubandakanya ukuqunjelwa sisisu, urhudo, isicaphucaphu, ukudinwa, intloko ebuhlungu kunye nentloko.

I-CLA yenziwa ikakhulu kwisibindi. Kwiimeko ezinqabileyo, i-CLA inokubangela ubuthi besibindi (ngesiqhelo kubantu abanesifo sesibindi). Iidosi ezinkulu zinokubangela ukuqokelela kwamafutha esibindini, okukhokelela kwisifo esinamafutha, isifo seswekile, kunye nesifo se-metabolic.

Ukudityaniswa kwe-asidi ye-linoleic kunokunciphisa ukucima kwegazi. Ukuthatha i-CLA yokuncedisa kunye ne-anticoagulant ("i-blood thinners") okanye i-nonsteroidal anti-inflammatory drug (NSAID) inokunyusa ngakumbi oku kusebenza, okukhokelela ekutyunyeni okulula kunye nokuphuma kwegazi.

 

I-linoleic acid edityanisiweyo (i-CLA) Ukusetyenziswa kunye nokusetyenziswa.

Ifakwe ekutyeni nakwizithako zesiselo;

Ifakwe kwizongezo zokuthambisa;

I-Acid esetyenziswe kwiimveliso zezempilo;

Ifakwe kwisongezelelo sesondlo;

Ifakwe kumzi mveliso wamayeza;

Isetyenziselwa ukunciphisa umzimba.

 

isingqiniso:

  • I-RC Khanal, TR Dhiman Biosynthesis ye-linoleic acid (CLA): uphononongo lwe-Pak. J. Nutr., 3 (2004), iphe. 72-81
  • I-Curr ye-linoleic acid metabolism ye-Conjugated. Opin. I-Lipidol., 13 (2002), iphe. 261-266
  • KW Lee Lee, HJ Lee, HY Cho, YJ Kim Indima ye-linojenic acid edibeneyo ekuthinteleni umhlaza. Umfu. Nutr., 45 (2005), iphe. 135-144
  • Tang, KV Honn 12 (S) -HETE kumhlaza metastasis Adv. Ukukhupha IMed. I-Biol., 447 (1999), iphe. 181-191 Churruca I et al. I-isomers ezihlanganisiweyo ze-linoleic acid: umahluko kwimetabolism kunye nefuthe lebhayoloji. I-Biofactors 2009; 35 (1): 105-11.